Results 41 to 50 of about 74,860 (159)

Current issues in patient adherence and persistence: focus on anticoagulants for the treatment and prevention of thromboembolism

open access: yesPatient Preference and Adherence, 2010
Patrick P Kneeland, Margaret C FangThe University of California, San Francisco Division of Hospital Medicine, San Francisco, CA, USAAbstract: Warfarin therapy reduces morbidity and mortality related to thromboembolism. Yet adherence to long-term warfarin
Patrick P Kneeland, Margaret C Fang
doaj  

Bound to bleed: How altered albumin binding may dictate warfarin treatment outcome

open access: yesInternational Journal of Cardiology: Heart & Vasculature, 2019
Although non-vitamin-K anticoagulants are now the preferred option for stroke prevention in atrial fibrillation (AF), warfarin is still used in a significant number of patients.
Anke C. Fender, Dobromir Dobrev
doaj   +1 more source

Protein binding interaction of warfarin and acetaminophen in presence of arsenic and of the biological system

open access: yesBangladesh Journal of Pharmacology, 2008
Equilibrium dialysis was used to study in vitro binding of acetaminophen at physiological pH and temperature in Bovine serum albumin (BSA). The binding of acetaminophen and warfarin mixture was studied to determine the effect of acetaminophen on the ...
Md. Ashraful Alam   +2 more
doaj   +1 more source

Ascorbic acid-induced warfarin resistance after breast cancer surgery: a case report and literature review

open access: yesFrontiers in Pharmacology
Warfarin is an anticoagulant that requires INR-based dosage adjustment. Ascorbic acid may impair warfarin effectiveness according to limited literature.
Pingfa Gao   +4 more
doaj   +1 more source

Effectiveness and safety of direct oral anticoagulants compared to warfarin in treatment naïve non-valvular atrial fibrillation patients in the US Department of defense population

open access: yesBMC Cardiovascular Disorders, 2019
Background Clinical trials have demonstrated that direct oral anticoagulants (DOACs) are at least non-inferior to warfarin in reducing the risk of stroke/systemic embolism (SE) among patients with non-valvular atrial fibrillation (NVAF), but the ...
Kiran Gupta   +7 more
doaj   +1 more source

Warfarin brands [PDF]

open access: yesAustralian Prescriber, 2015
Linda Graudins   +6 more
openaire   +2 more sources

ANALYSIS OF STRUCTURAL FEATURES OF THE KETO-KETAL ISOMERS OF WARFARIN BY SPECTRAL METHODS

open access: yesРазработка и регистрация лекарственных средств, 2019
As a result of the studies was shown that the relative ratios of isomers by integration in DMSO-d6: (S, R)-warfarin – (S, S)-warfarin – open chain warfarin are 70%: 28%: 2%; in СDCl3 are 45%: 40%: 15%.
A. Z. Abyshev   +2 more
doaj  

Warfarin use and vestibular dysfunction insights from NHANES data, network pharmacology, Mendelian randomization, and molecular docking

open access: yesScientific Reports
Despite numerous anticoagulants available, warfarin is widely used due to its efficacy and cost-effectiveness in treating thromboembolic diseases. However, its potential impact on vestibular function remains unexplored.
Shihan Liu, Lingli Zhang, Wenlong Luo
doaj   +1 more source

Piperine Alters the Pharmacokinetics and Anticoagulation of Warfarin in Rats

open access: yesJournal of Experimental Pharmacology, 2020
Aref Zayed,1 Wahby M Babaresh,1 Ruba S Darweesh,2 Tamam El-Elimat,1 Sahar S Hawamdeh1 1Department of Medicinal Chemistry and Pharmacognosy, Faculty of Pharmacy, Jordan University of Science and Technology, Irbid 22110, Jordan; 2Department of ...
Zayed A   +4 more
doaj  

Home - About - Disclaimer - Privacy